EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 6, Pages 1295
Publisher
MDPI AG
Online
2017-06-19
DOI
10.3390/ijms18061295
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Glioblastoma vaccine therapy disappointment in Phase III trial
- (2016) Hemi Malkki Nature Reviews Neurology
- EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation
- (2016) Eskil Eskilsson et al. NEURO-ONCOLOGY
- A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients
- (2015) J. J. Raizer et al. JOURNAL OF NEURO-ONCOLOGY
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- Notching on Cancer’s Door: Notch Signaling in Brain Tumors
- (2015) Marcin Teodorczyk et al. Frontiers in Oncology
- Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
- (2015) Emily Padfield et al. Frontiers in Oncology
- Quantitative Proteomic Analysis Reveals Effects of Epidermal Growth Factor Receptor (EGFR) on Invasion-promoting Proteins Secreted by Glioblastoma Cells
- (2014) Vineet Sangar et al. MOLECULAR & CELLULAR PROTEOMICS
- JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma
- (2014) Q. Zheng et al. NEURO-ONCOLOGY
- Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
- (2014) P. Y. Wen et al. NEURO-ONCOLOGY
- MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma
- (2014) Fei Wang et al. TUMOR BIOLOGY
- EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
- (2013) Krishna M. Talasila et al. ACTA NEUROPATHOLOGICA
- EGFL7 ligates v 3 integrin to enhance vessel formation
- (2013) I. Nikolic et al. BLOOD
- EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in Glioblastoma
- (2013) Qi-Wen Fan et al. CANCER CELL
- Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion
- (2013) Deborah Huveldt et al. PLoS One
- Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27KIP1 and MMP3 expression
- (2012) Xun Jin et al. CANCER LETTERS
- Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
- (2012) T. E. Taylor et al. CURRENT CANCER DRUG TARGETS
- The regulation of cysteine cathepsins and cystatins in human gliomas
- (2012) Boris Gole et al. INTERNATIONAL JOURNAL OF CANCER
- Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis
- (2012) H. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma
- (2012) D Kesanakurti et al. Cell Death & Disease
- Heterogeneity Maintenance in Glioblastoma: A Social Network
- (2011) R. Bonavia et al. CANCER RESEARCH
- Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway
- (2011) M. Anand et al. JOURNAL OF NEURO-ONCOLOGY
- Mechanism of p27 upregulation induced by downregulation of cathepsin B and uPAR in glioma
- (2011) Sreelatha Gopinath et al. Molecular Oncology
- EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
- (2011) R Bonavia et al. ONCOGENE
- Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells
- (2011) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effect of epidermal growth factor receptor variant III on glioma cell migration by stimulating ERK phosphorylation through the focal adhesion kinase signaling pathway
- (2010) Mingzhu Liu et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells
- (2010) Xiao Yue et al. BRAIN RESEARCH
- Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription
- (2010) Lei Han et al. BRAIN RESEARCH
- Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
- (2010) S. A. Grossman et al. CLINICAL CANCER RESEARCH
- Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma
- (2010) M.-d.-M. Inda et al. GENES & DEVELOPMENT
- Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin
- (2010) Melarkode S. Ramakrishnan et al. mAbs
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients
- (2009) K. V. Lu et al. CANCER RESEARCH
- Integrins
- (2009) Malgorzata Barczyk et al. CELL AND TISSUE RESEARCH
- Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma
- (2009) J.-S. Guillamo et al. CLINICAL CANCER RESEARCH
- EGF-Induced ERK Activation Promotes CK2-Mediated Disassociation of α-Catenin from β-Catenin and Transactivation of β-Catenin
- (2009) Haitao Ji et al. MOLECULAR CELL
- Src kinases as therapeutic targets for cancer
- (2009) Lori C. Kim et al. Nature Reviews Clinical Oncology
- Oncogenic EGFR Signaling Networks in Glioma
- (2009) P. H. Huang et al. Science Signaling
- Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth
- (2008) P Pu et al. CANCER GENE THERAPY
- Notch-1 regulates transcription of the epidermal growth factor receptor through p53
- (2008) Benjamin W. Purow et al. CARCINOGENESIS
- Trafficking of receptor tyrosine kinases to the nucleus
- (2008) Graham Carpenter et al. EXPERIMENTAL CELL RESEARCH
- Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway
- (2008) N. de la Iglesia et al. GENES & DEVELOPMENT
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
- (2008) Jinyan Du et al. NATURE BIOTECHNOLOGY
- The function of Stat3 in tumor cells and their microenvironment
- (2008) Bernd Groner et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCδ, and sphingosine kinase 1 in glioblastoma cells
- (2007) Barbara S. Paugh et al. FASEB JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started